Predictive Factors of Non-Elevation of Carcinoembryonic Antigen 125 in Acute Heart Failure
This study aims to analyze the factors associated with the lack of carbohydrate antigen 125 (CA-125) elevation in cases of acute heart failure (HF) decompensation. This retrospective study was conducted on 3167 consecutive patients admitted for acute HF in the cardiology department of a referral hospital (June 2019 to June 2024). Admissions from outpatient clinics (n: 1018) and transfers from other hospitals (n: 752) were excluded. The variables of interest included clinical, echocardiographic, therapeutic, and analytical factors. Low CA-125 levels were defined as values ≤ 50 U/mL. A total of 1397 patients were included, of whom 515 had normal CA-125 levels and 882 had elevated levels. Clinically, independent predictors of low CA-125 were sinus rhythm on electrocardiogram (OR: 1.42, 95% CI: 1.12-1.64; <i>p</i>: 0.003) and sleep apnea-hyponpnea syndrome (OR: 1.76, 95% CI: 1.15-2.70; <i>p</i>: 0.009). Echocardiographically, inferior vena cava collapse greater than 50% with inspiration was associated with low CA-125 (OR: 1.78, 95% CI: 1.19-2.69; <i>p</i> = 0.005), as well as with non-severe right ventricular dysfunction. (OR: 2.42; IC95%: 1.39-4.20; <i>p</i>: 0.002). Analytically, elevated NT-proBNP levels were associated with elevated CA-125 levels (OR: 0.99; IC95%: 0.99-0.99; <i>p</i>: 0.006). Survival was higher in the group with CA-125 ≤ 50 U/mL (<i>p</i>: 0.019). Conversely, as CA-125 values increased, mortality also rose. In conclusion, the absence of CA-125 elevation in patients admitted for acute HF is associated with sinus rhythm, sleep apnea-hyponpnea syndrome, low NT-proBNP levels, and inferior vena cava collapse greater than 50% with inspiration.
Authors
- Julia Martínez Solé (ORCID: https://orcid.org/0000-0001-8084-3531)
- Borja Guerrero Cervera (ORCID: https://orcid.org/0000-0003-3359-8857)
- Zoser Saura-Carretero (ORCID: https://orcid.org/0009-0000-7264-8840)
- Víctor José Donoso Trenado (ORCID: https://orcid.org/0000-0002-3105-9529)
- Luis Martínez‐Dolz (ORCID: https://orcid.org/0000-0001-5145-8191)
- Luis Almenar‐Bonet (ORCID: https://orcid.org/0000-0002-7710-361X)
- Raquel López‐Vilella (ORCID: https://orcid.org/0000-0002-9696-2313)
- Sara Huélamo Montoro
- Francisco González-Vı́lchez
Institutions
- Instituto de Salud Carlos III (ES)
- Hospital Universitari i Politècnic La Fe (ES)
- Centro de Investigación en Red en Enfermedades Cardiovasculares (ES)
- Marqués de Valdecilla University Hospital (ES)
- Centro de Investigación Biomédica en Red (ES)
Publication Details
- Journal
- Life
- Published
- 2025-03-18
- DOI
- https://doi.org/10.3390/life15030494
- Citations
- 4
- Primary Topic
- Heart Failure Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 5.55